A Guide to Transitioning to Biologic Therapy for IBD

You and your physician have decided to start biologic therapy for your IBD. So what does this mean? Well, biologics have been a part of medical treatment since the 1980s and since 1998 and IBD specifically. They are antibodies created in the laboratory from living cells that stop certain proteins in the body from causing inflammation.
You will likely be prescribed a biosimilar, which is created using the same laboratory process as an original biologic. Biosimilars have been used to treat IBD since 2006 globally and in Canada since 2009 with no clinically meaningful differences in safety and efficacy compared to an original biologic. By selectively targeting particular proteins, your biosimilar treatment will help you control inflammation and achieve and maintain remission time for a change is now.
For more information visit CDHF.ca